Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
248.7 USD | +0.43% | +1.43% | +29.92% |
03/07 | Jerome Powell did it again | |
03/07 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.92% | 3.13TCr | |
+16.59% | 4.49TCr | |
-10.62% | 3.78TCr | |
+40.49% | 3.76TCr | |
-9.78% | 2.74TCr | |
+12.34% | 2.63TCr | |
+41.53% | 1.41TCr | |
+31.49% | 1.25TCr | |
-7.40% | 1.12TCr | |
-14.80% | 1.04TCr |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-07-2019 through Jan-10-2019